Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.40
ANTM's Cash-to-Debt is ranked lower than
78% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.12 vs. ANTM: 0.40 )
Ranked among companies with meaningful Cash-to-Debt only.
ANTM' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09  Med: 0.25 Max: N/A
Current: 0.4
Equity-to-Asset 0.38
ANTM's Equity-to-Asset is ranked higher than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.38 vs. ANTM: 0.38 )
Ranked among companies with meaningful Equity-to-Asset only.
ANTM' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.33  Med: 0.44 Max: 0.51
Current: 0.38
0.33
0.51
Interest Coverage 6.17
ANTM's Interest Coverage is ranked lower than
77% of the 22 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.59 vs. ANTM: 6.17 )
Ranked among companies with meaningful Interest Coverage only.
ANTM' s Interest Coverage Range Over the Past 10 Years
Min: 6.17  Med: 7.41 Max: 16.55
Current: 6.17
6.17
16.55
Beneish M-Score: -2.45
WACC vs ROIC
5.59%
15.67%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 5.46
ANTM's Operating Margin % is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.07 vs. ANTM: 5.46 )
Ranked among companies with meaningful Operating Margin % only.
ANTM' s Operating Margin % Range Over the Past 10 Years
Min: 5.1  Med: 6.09 Max: 11.38
Current: 5.46
5.1
11.38
Net Margin % 3.19
ANTM's Net Margin % is ranked higher than
52% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.91 vs. ANTM: 3.19 )
Ranked among companies with meaningful Net Margin % only.
ANTM' s Net Margin % Range Over the Past 10 Years
Min: 2.91  Med: 4.19 Max: 7.3
Current: 3.19
2.91
7.3
ROE % 11.22
ANTM's ROE % is ranked lower than
76% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.02 vs. ANTM: 11.22 )
Ranked among companies with meaningful ROE % only.
ANTM' s ROE % Range Over the Past 10 Years
Min: 10.25  Med: 11.23 Max: 20.5
Current: 11.22
10.25
20.5
ROA % 4.25
ANTM's ROA % is ranked lower than
52% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.98 vs. ANTM: 4.25 )
Ranked among companies with meaningful ROA % only.
ANTM' s ROA % Range Over the Past 10 Years
Min: 3.9  Med: 4.88 Max: 9.44
Current: 4.25
3.9
9.44
3-Year Revenue Growth Rate 10.60
ANTM's 3-Year Revenue Growth Rate is ranked higher than
50% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. ANTM: 10.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ANTM' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 12.2 Max: 18.2
Current: 10.6
0
18.2
3-Year EBITDA Growth Rate 9.40
ANTM's 3-Year EBITDA Growth Rate is ranked lower than
58% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.60 vs. ANTM: 9.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ANTM' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 11.9 Max: 24.9
Current: 9.4
0
24.9
3-Year EPS without NRI Growth Rate 2.00
ANTM's 3-Year EPS without NRI Growth Rate is ranked lower than
67% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.30 vs. ANTM: 2.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ANTM' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 7.5 Max: 27
Current: 2
0
27
GuruFocus has detected 6 Warning Signs with Anthem Inc $ANTM.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ANTM's 10-Y Financials

Financials (Next Earnings Date: 2017-07-26 Est.)


Revenue & Net Income
Equity & Asset
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

ANTM Guru Trades in Q2 2016

Joel Greenblatt 34,769 sh (New)
Paul Tudor Jones 15,254 sh (+535.58%)
Jim Simons 1,196,973 sh (+193.95%)
Ray Dalio 43,000 sh (+127.51%)
First Eagle Investment 2,331,026 sh (+55.25%)
Barrow, Hanley, Mewhinney & Strauss 8,575,511 sh (+17.98%)
Lee Ainslie 9,300 sh (+10.32%)
Larry Robbins 3,959,416 sh (+8.63%)
HOTCHKIS & WILEY 2,465,551 sh (+7.70%)
David Dreman 6,094 sh (+4.78%)
Jeremy Grantham 1,130,477 sh (+1.35%)
Donald Yacktman 1,056,204 sh (+0.08%)
Yacktman Fund 850,000 sh (unchged)
Vanguard Health Care Fund 3,517,033 sh (unchged)
Tom Gayner 224,000 sh (unchged)
Jeff Auxier 56,044 sh (unchged)
George Soros 157,600 sh (unchged)
Bernard Horn 36,600 sh (unchged)
Andreas Halvorsen Sold Out
George Soros Sold Out
Steven Cohen Sold Out
T Rowe Price Equity Income Fund 1,769,400 sh (-0.13%)
Dodge & Cox 3,205,245 sh (-5.24%)
First Pacific Advisors 41,350 sh (-17.22%)
» More
Q3 2016

ANTM Guru Trades in Q3 2016

Steven Cohen 61,000 sh (New)
Signature Select Canadian Fund 72,650 sh (New)
Ray Dalio 74,679 sh (+73.67%)
HOTCHKIS & WILEY 3,707,313 sh (+50.36%)
Larry Robbins 5,597,242 sh (+41.37%)
First Eagle Investment 2,823,567 sh (+21.13%)
T Rowe Price Equity Income Fund 2,100,000 sh (+18.68%)
Lee Ainslie 9,480 sh (+1.94%)
Yacktman Fund 850,000 sh (unchged)
Tom Gayner 224,000 sh (unchged)
David Dreman 6,094 sh (unchged)
Bernard Horn 36,600 sh (unchged)
Paul Tudor Jones Sold Out
Donald Yacktman 1,055,235 sh (-0.09%)
Jim Simons 1,176,800 sh (-1.69%)
Barrow, Hanley, Mewhinney & Strauss 8,414,907 sh (-1.87%)
Jeff Auxier 54,844 sh (-2.14%)
Dodge & Cox 3,111,405 sh (-2.93%)
Vanguard Health Care Fund 3,209,633 sh (-8.74%)
First Pacific Advisors 32,450 sh (-21.52%)
Jeremy Grantham 779,806 sh (-31.02%)
Joel Greenblatt 19,304 sh (-44.48%)
» More
Q4 2016

ANTM Guru Trades in Q4 2016

Daniel Loeb 1,000,000 sh (New)
Paul Tudor Jones 4,800 sh (New)
NWQ Managers 9,000 sh (New)
Joel Greenblatt 28,408 sh (+47.16%)
Jim Simons 1,686,773 sh (+43.34%)
First Pacific Advisors 37,700 sh (+16.18%)
Larry Robbins 5,874,049 sh (+4.95%)
T Rowe Price Equity Income Fund 2,140,000 sh (+1.90%)
First Eagle Investment 2,825,954 sh (+0.08%)
Yacktman Fund 850,000 sh (unchged)
Tom Gayner 224,000 sh (unchged)
Bernard Horn 36,600 sh (unchged)
Ray Dalio 74,604 sh (-0.10%)
Jeff Auxier 54,694 sh (-0.27%)
Donald Yacktman 1,038,140 sh (-1.62%)
HOTCHKIS & WILEY 3,635,567 sh (-1.94%)
Dodge & Cox 3,005,018 sh (-3.42%)
Barrow, Hanley, Mewhinney & Strauss 8,053,028 sh (-4.30%)
Lee Ainslie 8,530 sh (-10.02%)
Jeremy Grantham 701,535 sh (-10.04%)
Vanguard Health Care Fund 2,666,933 sh (-16.91%)
David Dreman 4,815 sh (-20.99%)
Steven Cohen 5,000 sh (-91.80%)
» More
Q1 2017

ANTM Guru Trades in Q1 2017

Yacktman Fund 850,000 sh (unchged)
Tom Gayner 224,000 sh (unchged)
T Rowe Price Equity Income Fund 2,120,000 sh (-0.93%)
» More
» Details

Insider Trades

Latest Guru Trades with ANTM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:AET, NYSE:CI, NAS:ESRX, NYSE:HUM, NYSE:CNC, NYSE:CVS, NYSE:WCG, NYSE:MOH, NAS:MGLN, NYSE:UAM, NAS:HIIQ, OTCPK:WCUI, OTCPK:OPRX, NAS:CNXR, NYSE:UNH » details
Traded in other countries:A58.Germany, ANTM.Mexico,
Headquarter Location:USA
Anthem Inc is a health benefits company offering a network-based managed care plans to the large and small employer, individual, Medicaid and Medicare markets.

With approximately 40 million medical members, Anthem is one of the largest managed-care organizations in the United States. The firm provides health insurance services to its members through a plethora of products that encompass every major insurance market--individual, group, and government-sponsored. The firm operates under the highly recognizable Blue Cross/Blue Shield brand in 14 states and has a large nationwide operation.

Guru Investment Theses on Anthem Inc

Bernard Horn Comments on Anthem - Apr 21, 2017

From the outset, investors and analysts raised concerns about the proposed merger between U.S. health insurers, Anthem, Inc. and Cigna. In early January 2017, a federal judge blocked the proposed merger, siding with the Department of Justice. Anthem (NYSE:ANTM) stock rose in the ensuing three months, up more than 15% at the end of March, as investors were relieved about the deal cancellation. In February, the Centers for Medicare & Medicaid Services proposed rules aimed at stabilizing the Affordable Care Act (ACA) individual and small group insurance markets. This bodes well for Anthem Inc., and other health insurers, as the rule may help stem the tide of financial losses currently associated with ACA participation.

From Bernard Horn (Trades, Portfolio)'s Polaris Global Fund first quarter 2017 shareholder letter.

Check out Bernard Horn latest stock trades

Bernard Horn Comments on Anthem Inc. - Mar 21, 2016

M&A activity was also heating up in the health insurer industry, with the CFO of Anthem Inc. (NYSE:ANTM) suggesting the company could make a “meaningful” acquisition. Thereafter, Anthem entered negotiations to buy Cigna. In addition to this strategy, Anthem also announced strong earnings, deploying capital in the form of share buybacks and dividends.

From Bernard Horn (Trades, Portfolio)'s Global Value Fund annual letter 2015.



Check out Bernard Horn latest stock trades

Top Ranked Articles about Anthem Inc

Bernard Horn Comments on Anthem Guru stock highlight
From the outset, investors and analysts raised concerns about the proposed merger between U.S. health insurers, Anthem, Inc. and Cigna. In early January 2017, a federal judge blocked the proposed merger, siding with the Department of Justice. Anthem (NYSE:ANTM) stock rose in the ensuing three months, up more than 15% at the end of March, as investors were relieved about the deal cancellation. In February, the Centers for Medicare & Medicaid Services proposed rules aimed at stabilizing the Affordable Care Act (ACA) individual and small group insurance markets. This bodes well for Anthem Inc., and other health insurers, as the rule may help stem the tide of financial losses currently associated with ACA participation. Read more...
Investor Confidence in Cigna and Anthem Rises as Health Care Mergers Dealt Blows Both companies gained as dates for decisions pushed back to Trump administration
As a judge struck down a mega merger between health care giants Aetna (NYSE:AET) and Humana (NYSE:HUM) on Tuesday, investor confidence seemed to grow for two other companies seeking to unite in a similar deal, Cigna (NYSE:CI) and Anthem (NYSE:ANTM). Read more...
15 Best Undervalued Stocks of the Week Companies reviewed by ModernGraham
I evaluated 35 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. I also put each company through the ModernGraham valuation model, based on Benjamin Graham's value investing formulas, in order to determine an intrinsic value for each. Out of those 35 companies, only 15 were found to be undervalued or fairly valued and suitable for either Defensive or Enterprising Investors. Therefore, these 5 companies are the best undervalued stocks of the week. Read more...

Ratios

vs
industry
vs
history
PE Ratio 17.25
ANTM's PE Ratio is ranked higher than
61% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.35 vs. ANTM: 17.25 )
Ranked among companies with meaningful PE Ratio only.
ANTM' s PE Ratio Range Over the Past 10 Years
Min: 4.33  Med: 10.53 Max: 17.89
Current: 17.25
4.33
17.89
Forward PE Ratio 15.38
ANTM's Forward PE Ratio is ranked higher than
97% of the 36 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.62 vs. ANTM: 15.38 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 17.25
ANTM's PE Ratio without NRI is ranked higher than
65% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 21.38 vs. ANTM: 17.25 )
Ranked among companies with meaningful PE Ratio without NRI only.
ANTM' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.33  Med: 10.38 Max: 17.89
Current: 17.25
4.33
17.89
Price-to-Owner-Earnings 12.59
ANTM's Price-to-Owner-Earnings is ranked lower than
63% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.58 vs. ANTM: 12.59 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ANTM' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 4.85  Med: 11.71 Max: 213.36
Current: 12.59
4.85
213.36
PB Ratio 1.81
ANTM's PB Ratio is ranked higher than
87% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.55 vs. ANTM: 1.81 )
Ranked among companies with meaningful PB Ratio only.
ANTM' s PB Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.15 Max: 2.11
Current: 1.81
0.71
2.11
PS Ratio 0.55
ANTM's PS Ratio is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.57 vs. ANTM: 0.55 )
Ranked among companies with meaningful PS Ratio only.
ANTM' s PS Ratio Range Over the Past 10 Years
Min: 0.27  Med: 0.44 Max: 0.98
Current: 0.55
0.27
0.98
Price-to-Free-Cash-Flow 12.18
ANTM's Price-to-Free-Cash-Flow is ranked lower than
63% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.11 vs. ANTM: 12.18 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ANTM' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.96  Med: 11.42 Max: 50.22
Current: 12.18
5.96
50.22
Price-to-Operating-Cash-Flow 10.57
ANTM's Price-to-Operating-Cash-Flow is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.41 vs. ANTM: 10.57 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ANTM' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.3  Med: 9.92 Max: 26.95
Current: 10.57
5.3
26.95
EV-to-EBIT 6.82
ANTM's EV-to-EBIT is ranked higher than
93% of the 43 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.77 vs. ANTM: 6.82 )
Ranked among companies with meaningful EV-to-EBIT only.
ANTM' s EV-to-EBIT Range Over the Past 10 Years
Min: 2.1  Med: 6 Max: 11.4
Current: 6.82
2.1
11.4
EV-to-EBITDA 5.86
ANTM's EV-to-EBITDA is ranked higher than
93% of the 45 Companies
in the Global Health Care Plans industry.

( Industry Median: 8.48 vs. ANTM: 5.86 )
Ranked among companies with meaningful EV-to-EBITDA only.
ANTM' s EV-to-EBITDA Range Over the Past 10 Years
Min: 1.8  Med: 5.2 Max: 9.9
Current: 5.86
1.8
9.9
PEG Ratio 1.49
ANTM's PEG Ratio is ranked higher than
64% of the 14 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.87 vs. ANTM: 1.49 )
Ranked among companies with meaningful PEG Ratio only.
ANTM' s PEG Ratio Range Over the Past 10 Years
Min: 0.35  Med: 0.71 Max: 4.97
Current: 1.49
0.35
4.97
Shiller PE Ratio 20.60
ANTM's Shiller PE Ratio is ranked higher than
77% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.26 vs. ANTM: 20.60 )
Ranked among companies with meaningful Shiller PE Ratio only.
ANTM' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.12  Med: 14.23 Max: 22.2
Current: 20.6
9.12
22.2

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.46
ANTM's Dividend Yield % is ranked higher than
58% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.29 vs. ANTM: 1.46 )
Ranked among companies with meaningful Dividend Yield % only.
ANTM' s Dividend Yield % Range Over the Past 10 Years
Min: 0.31  Med: 1.59 Max: 2.16
Current: 1.46
0.31
2.16
Dividend Payout Ratio 0.25
ANTM's Dividend Payout Ratio is ranked higher than
77% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.33 vs. ANTM: 0.25 )
Ranked among companies with meaningful Dividend Payout Ratio only.
ANTM' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.14  Med: 0.18 Max: 0.28
Current: 0.25
0.14
0.28
3-Year Dividend Growth Rate 20.10
ANTM's 3-Year Dividend Growth Rate is ranked higher than
62% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. ANTM: 20.10 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
ANTM' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 29.5
Current: 20.1
0
29.5
Forward Dividend Yield % 1.46
ANTM's Forward Dividend Yield % is ranked higher than
88% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.52 vs. ANTM: 1.46 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 4.04
ANTM's 5-Year Yield-on-Cost % is ranked lower than
53% of the 34 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.08 vs. ANTM: 4.04 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
ANTM' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.88  Med: 4.49 Max: 6.11
Current: 4.04
0.88
6.11
3-Year Average Share Buyback Ratio 3.50
ANTM's 3-Year Average Share Buyback Ratio is ranked higher than
78% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.00 vs. ANTM: 3.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ANTM' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -43.1  Med: 8.55 Max: 0
Current: 3.5
-43.1
0

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 77.55
ANTM's Price-to-Tangible-Book is ranked lower than
99.99% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.31 vs. ANTM: 77.55 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ANTM' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.72  Med: 12.93 Max: 180.12
Current: 77.55
1.72
180.12
Price-to-Intrinsic-Value-Projected-FCF 0.74
ANTM's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
81% of the 16 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.01 vs. ANTM: 0.74 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ANTM' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.32  Med: 0.47 Max: 1.47
Current: 0.74
0.32
1.47
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.45
ANTM's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
55% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.39 vs. ANTM: 1.45 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.25
ANTM's Price-to-Median-PS-Value is ranked lower than
57% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.91 vs. ANTM: 1.25 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ANTM' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.73  Med: 1.11 Max: 2.54
Current: 1.25
0.73
2.54
Price-to-Peter-Lynch-Fair-Value 1.51
ANTM's Price-to-Peter-Lynch-Fair-Value is ranked higher than
55% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.50 vs. ANTM: 1.51 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ANTM' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.37  Med: 0.72 Max: 3.13
Current: 1.51
0.37
3.13
Price-to-Graham-Number 7.71
ANTM's Price-to-Graham-Number is ranked lower than
99.99% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.61 vs. ANTM: 7.71 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ANTM' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.02  Med: 2.4 Max: 11.61
Current: 7.71
1.02
11.61
Earnings Yield (Greenblatt) % 14.66
ANTM's Earnings Yield (Greenblatt) % is ranked higher than
93% of the 42 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.29 vs. ANTM: 14.66 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ANTM' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 8.8  Med: 16.75 Max: 47.8
Current: 14.66
8.8
47.8
Forward Rate of Return (Yacktman) % 17.39
ANTM's Forward Rate of Return (Yacktman) % is ranked lower than
53% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 17.81 vs. ANTM: 17.39 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ANTM' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 7.7  Med: 21.3 Max: 42.9
Current: 17.39
7.7
42.9

More Statistics

Revenue (TTM) (Mil) $87,100
EPS (TTM) $ 10.31
Beta0.72
Short Percentage of Float2.56%
52-Week Range $114.85 - 184.45
Shares Outstanding (Mil)264.99

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 97,133 102,076 96,591
EPS ($) 12.33 12.68 14.13
EPS without NRI ($) 12.33 12.68 14.13
EPS Growth Rate
(Future 3Y To 5Y Estimate)
6.32%
Dividends per Share ($) 2.62 2.43 2.78
» More Articles for ANTM

Headlines

Articles On GuruFocus.com
Bernard Horn Comments on Anthem Apr 21 2017 
Bernard Horn's 1st Quarter 2017 Polaris Global Fund Commentary Apr 21 2017 
High Predictability Guru Stocks Apr 10 2017 
Analysts Release New Health Care Stock Ratings Apr 07 2017 
A Market of Extremes Mar 14 2017 
Since the Merger With Cigna Seems Doomed, What Are We to Think of Anthem? Feb 22 2017 
Jeff Auxier's Year-End 2016 Market Commentary Feb 08 2017 
Investor Confidence in Cigna and Anthem Rises as Health Care Mergers Dealt Blows Jan 25 2017 
9 Stocks Ray Dalio Continues to Buy Dec 22 2016 
The Top 5 Buys of the Signature Select Canadian Fund Dec 15 2016 

More From Other Websites
Unbundling Billionaire Larry Robbins’ Portfolio Apr 29 2017
[$$] No Easy Remedy for Express Scripts Stock Apr 28 2017
Appeals court upholds decision to block Anthem bid for Cigna Apr 28 2017
With Anthem-Cigna All But Dead, M&A Speculation Is Back On Apr 28 2017
U.S. appeals court blocks Anthem bid to merge with rival Cigna Apr 28 2017
Analysts’ Recommendations for Anthem in 2017 Apr 28 2017
Anthem Responds to U.S. Court of Appeals Decision on Acquisition of Cigna Apr 28 2017
Anthem-Cigna Drama Shifts to $15 Billion Spat Over Merger Apr 28 2017
ETFs with exposure to Anthem, Inc. : April 28, 2017 Apr 28 2017
Why Anthem Reported Strong Revenue Growth in 1Q17 Apr 28 2017
Anthem-Cigna Deal Likely Dead After Appeals Court Rejection Apr 28 2017
DC Circuit Court Upholds Block of Anthem, Cigna Merger Apr 28 2017
Anthem Loses Appeal to Overturn U.S. Block of Cigna Takeover Apr 28 2017
Zacks.com featured highlights: Darden Restaurants, Louisiana-Pacific, Anthem, Huntington Ingalls... Apr 28 2017
Edited Transcript of ANTM earnings conference call or presentation 26-Apr-17 12:30pm GMT Apr 27 2017
Centene Reported Strong Revenue Growth in 1Q17 Apr 27 2017
Anthem, Inc. :ANTM-US: Earnings Analysis: Q1, 2017 By the Numbers : April 27, 2017 Apr 27 2017
Anthem Blue Cross Nears 60% Value-Based Care Spend Apr 27 2017
Express Scripts stock surges on investor hopes for an Anthem reconciliation Apr 27 2017
Anthem could bolt from Obamacare exchange if subsidies are cut Apr 26 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)